T

    Theriva Biologics Inc. (TOVX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NYSE MKT

    $0.25
    +0.01 (+2.57%)

    Market Cap: $11.25M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(26/40)
    Avg Surprise
    -35.10%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.05
    Range$-0.05 - $-0.05
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.16-220.0%
    60d ago$-0.16-220.0%
    30d ago$-0.05+0.0%
    7d ago$-0.05+0.0%
    Current$-0.05
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    Dec 31, 2026
    EPS Consensus$-0.05
    Range$-0.05 - $-0.05
    1 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    0 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.05---
    Sep 26EST
    		-$-0.05---
    Jun 26
    		$-0.07$-0.05-40.00%Miss+96.4%
    Mar 26
    		$-0.05$-0.05+0.00%Beat+96.8%
    Dec 25
    		$-0.10N/A+73.46%Beat+99.1%
    Sep 25
    		$-0.45$-0.38-18.42%Miss+93.4%
    Jun 25
    		$-1.93$-0.47-310.64%Miss+82.0%
    Mar 25
    		$-1.55$-1.56+0.64%Beat+79.3%
    Dec 24
    		$-11.49$-7.22-59.14%Miss-3279.4%
    Sep 24
    		$-6.81$-5.25-29.71%Miss-43.4%
    Jun 24
    		$-10.75$-4.75-126.32%Miss-26.5%
    Mar 24
    		$-7.50$-8.50+11.76%Beat+0.0%
    Dec 23
    		$-0.34$-0.41+17.07%Beat-3.0%
    Sep 23
    		$-4.75$-8.50+44.12%Beat+42.4%
    Jun 23
    		$-8.50$-8.50+0.00%Beat-9.7%
    Mar 23
    		$-7.50$-8.00+6.25%Beat-2400.0%
    Dec 22
    		$-0.33$-0.33+0.00%Beat+96.7%
    Sep 22
    		$-8.25$-11.25+26.67%Beat-65.0%
    Jun 22
    		$-7.75$-7.50-3.33%Miss-55.0%
    Mar 22
    		$-0.30$-0.30+0.00%Beat+99.1%
    Dec 21
    		$-10.00$-5.00-100.00%Miss-614.3%
    Sep 21
    		$-5.00$-5.00+0.00%Beat+85.7%
    Jun 21
    		$-5.00$-5.00+0.00%Beat+88.9%
    Mar 21
    		$-32.50$-5.00-550.00%Miss-1811.8%
    Dec 20
    		$-1.40$-0.80-75.00%Miss+97.1%
    Sep 20
    		$-35.00$-40.00+12.50%Beat+54.8%
    Jun 20
    		$-45.00$-35.00-28.57%Miss-1945.5%
    Mar 20
    		$-1.70$-2.70+37.04%Beat+22.7%
    Dec 19
    		$-47.50$-57.50+17.39%Beat+85.7%
    Sep 19
    		$-77.50$-57.50-34.78%Miss+66.7%
    Jun 19
    		$-2.20$-2.30+4.35%Beat+99.2%
    Mar 19
    		$-2.20$-2.30+4.35%Beat+98.7%
    Dec 18
    		$-332.50$-48.75-582.05%Miss-4850.0%
    Sep 18
    		$-232.50N/A+55.71%Beat+81.0%
    Jun 18
    		$-262.50$-350.00+25.00%Beat+0.0%
    Mar 18
    		$-175.00N/A+60.00%Beat+0.0%
    Dec 17
    		$7.00N/A+142.87%Beat+200.0%
    Sep 17
    		$-1225.00$-437.50-180.00%Miss-42.0%
    Jun 17
    		$-262.50$-495.83+47.06%Beat-
    Mar 17
    		$-175.00N/A+72.73%Beat-
    Dec 16
    		$-7.00N/A+73.68%Beat-
    Sep 16
    		$-862.75$-875.00+1.40%Beat-

    Key Metrics

    Valuation
    P/E Ratio-0.38EV/EBITDA1.72x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-4022.00%
    ROE-101.90%ROIC-57.08%
    Financial Health
    Debt/Equity0.35xInterest CoverageN/A
    Current Ratio1.13xQuick Ratio1.13x
    Trading Statistics
    Beta1.12Avg Volume554.19K
    52-Week High$0.8652-Week Low$0.16

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.24
    SMA 20$0.23
    SMA 50$0.23
    SMA 200$0.24
    EMA 10$0.24
    EMA 20$0.24
    EMA 50$0.24
    EMA 200$0.30

    MACD

    Line: 0.00Signal: 0.00Hist: 0.00

    ADX

    ADX: 29.0+DI: 23.5-DI: 8.4

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down4.0
    PSAR$0.23

    Bollinger Bands

    Upper Band$0.25
    Lower Band$0.22
    %B Position1531%(Upper)
    Band Width0.99

    RSI (14-Day)

    Neutral
    59.7

    Momentum Oscillators

    Stoch %K70.5
    Stoch %D68.0
    Williams %R-25.4
    ROC (10d)5.8%
    Momentum0.01
    CCI (20d)173.7
    MFI (14d)77.9

    Volatility Measures

    ATR (14d)$0.02(6.1%)
    StdDev (20d)0.01
    Hist Vol44.8%(High)

    Volume Flow

    VWAP$0.25
    OBV2.4B
    AD Line-1.6B
    CMF (20d)-0.165

    Volume Metrics

    Avg Vol (20d)565.3K
    Vol Ratio0.5x
    VWMA (20d)$0.24

    Pivot Points

    R3$0.27
    R2$0.27
    R1$0.26
    Pivot Point$0.25
    S1$0.24
    S2$0.23
    S3$0.22

    Advanced Oscillators

    TSI8.26
    Ultimate Osc41.9
    KST38.45

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$300,000$0$0$0$0$154,000$0$0$0$758,000$0
    Cost of Revenue$0$0$27,000$0$0$0$27,000$0$0$0$39,000$0
    Gross Profit$0$300,000$-27,000$0$0$0$-27,000$0$0$0$-39,000$0
    Operating Expenses$3.29M$2.43M$2.06M$4.44M$13.13M$4.42M$4.58M$7.89M$8.49M$5.39M$6.21M$4.22M
    R&D$1.27M$355,000$1.13M$2.55M$1.95M$2.97M$2.88M$2.73M$2.95M$3.46M$4.20M$4.01M
    SG&A$2.03M$2.07M$930,000$1.89M$11.18M$1.45M$1.69M$2.30M$1.47M$1.93M$2.02M$212,000
    Operating Income$-3,295,000$-2,127,000$-2,062,000$-4,440,000$-13,132,000$-4,417,000$-4,579,000$-7,887,000$-8,488,000$-5,392,000$-6,215,000$-4,218,000
    Interest Income$79,000$82,000$72,000$65,000$54,000$96,000$138,000$158,000$173,000$228,000$312,000$382,000
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-3,217,000$-2,044,000$-1,996,000$-4,361,000$-13,058,000$-4,324,000$-4,446,000$-7,726,000$-8,316,000$-5,165,000$-5,908,000$-3,830,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$-424,000$-527,000
    Net Income$-3,217,000$-2,044,000$-1,996,000$-4,361,000$-13,058,000$-4,324,000$-4,446,000$-7,726,000$-8,316,000$-5,165,000$-5,484,000$-3,303,000
    EBITDA$-3,272,000$-2,102,000$-2,041,000$-4,398,000$-13,085,000$-4,394,000$-4,557,000$-7,851,000$-8,451,000$-5,354,000$-6,181,000$-4,180,000
    EBIT$-3,296,000$-2,126,000$-2,068,000$-4,426,000$-13,112,000$-4,420,000$-4,584,000$-7,884,000$-8,489,000$-5,393,000$-6,220,000$-4,212,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TOVX

    News

    Theriva Biologics(TOVX) Stock Options Chain | Quotes & News

    This article provides access to the stock options chain, quotes, and news for Theriva Biologics (TOVX). It serves as a resource for investors looking for detailed financial information and trading tools related to TOVX. The content is primarily a gateway to real-time market data and related news.

    Moomoo•8/18/26•
    Neutral

    Maxim Group Maintains Theriva Biologics(TOVX.US) With Buy Rating, Maintains Target Price $1

    Maxim Group has reiterated its Buy rating for Theriva Biologics (TOVX.US) and maintained its price target of $1. This indicates continued confidence from the firm in the company's prospects.

    Moomoo•8/12/26•
    Bullish

    Theriva™ Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results

    Theriva™ Biologics reported its Q2 2026 operational highlights and financial results, noting the dosing of the first patients in the VIRAGE2 Phase 2a clinical study for metastatic pancreatic ductal adenocarcinoma (PDAC) with VCN-01. The company also discussed progress in retinoblastoma and head & neck squamous cell carcinoma programs, alongside financial figures showing cash and cash equivalents of $11.3 million and a decreased net loss compared to the prior year.

    Yahoo Finance UK•8/12/26•
    Bullish

    Theriva Biologics Releases Q2 2026 Financial Results

    Theriva Biologics (TOVX) reported a net loss of $3.2M for Q2 2026, with a loss per share of $0.07. This represents a significant improvement from the previous year, as the clinical-stage company continues to develop its pipeline targeting cancer. Analysts maintain a positive outlook on the stock, with 5 buy ratings and 1 hold rating.

    AlphaStreet•8/11/26•
    Somewhat-Bullish

    Form 8K Theriva Biologics Inc For: 11 August By Investing.com

    This article announces that Theriva Biologics Inc. filed a Form 8K on August 11. The filing is brief and does not contain additional details beyond the company name and date of the filing. It also includes general market data and other popular news articles from Investing.com.

    Investing.com Nigeria•8/11/26•
    Neutral

    Frequently Asked Questions About TOVX

    Does TOVX pay dividends?
    Theriva Biologics Inc. (TOVX) does not currently pay a regular dividend.
    What is TOVX's market cap?
    Theriva Biologics Inc. (TOVX) has a market capitalization of $11.25M with a current stock price of $0.25.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In